Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1944 1
1948 1
1949 1
1952 1
1953 1
1957 1
1960 2
1961 1
1962 1
1963 1
1964 1
1966 5
1967 7
1968 4
1969 7
1970 11
1971 10
1972 14
1973 11
1974 6
1975 20
1976 13
1977 23
1978 20
1979 12
1980 9
1981 24
1982 17
1983 20
1984 35
1985 24
1986 21
1987 29
1988 36
1989 27
1990 39
1991 28
1992 37
1993 23
1994 34
1995 63
1996 46
1997 65
1998 60
1999 70
2000 89
2001 107
2002 137
2003 148
2004 177
2005 196
2006 210
2007 254
2008 249
2009 287
2010 294
2011 325
2012 350
2013 410
2014 496
2015 503
2016 561
2017 615
2018 704
2019 744
2020 1024
2021 1281
2022 1322
2023 1317
2024 387

Text availability

Article attribute

Article type

Publication date

Search Results

11,760 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
Planchard D, Jänne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, Kobayashi K; FLAURA2 Investigators. Planchard D, et al. Among authors: ahmed s. N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes.
Waibel M, Wentworth JM, So M, Couper JJ, Cameron FJ, MacIsaac RJ, Atlas G, Gorelik A, Litwak S, Sanz-Villanueva L, Trivedi P, Ahmed S, Martin FJ, Doyle ME, Harbison JE, Hall C, Krishnamurthy B, Colman PG, Harrison LC, Thomas HE, Kay TWH; BANDIT Study Group. Waibel M, et al. Among authors: ahmed s. N Engl J Med. 2023 Dec 7;389(23):2140-2150. doi: 10.1056/NEJMoa2306691. N Engl J Med. 2023. PMID: 38055252 Clinical Trial.
Mucopolysaccharidosis.
Bhakthaganesh K, Manumuraleekrishna, Vanathi M, Ahmed S, Gupta N, Tandon R. Bhakthaganesh K, et al. Among authors: ahmed s. Taiwan J Ophthalmol. 2023 Nov 28;13(4):443-450. doi: 10.4103/tjo.TJO-D-23-00137. eCollection 2023 Oct-Dec. Taiwan J Ophthalmol. 2023. PMID: 38249505 Free PMC article. Review.
Physical activity and quality of life among breast cancer survivors.
Ammar N, Ezzairi F, Omri N, Ammar A, Ezzi O, Ben El Ghali T, Mahjoub M, Chabchoub I, Ben Ahmed S, Njah M. Ammar N, et al. Among authors: ben ahmed s. Tunis Med. 2024 Mar 5;102(3):157-163. doi: 10.62438/tunismed.v102i3.4293. Tunis Med. 2024. PMID: 38545711 French.
Prioritizing Mentorship as Scientific Leaders.
Deng JM, Ahmed SE, Awoonor-Williams E, Banerjee P, Barecka MH, Bickerton LE, Di Pietro SA, Dorn SK, Jablonka KM, Laudadio G, Kreidt E, Mannochio-Russo H, Terra J, Wilkins OH, Yerneni SS, Yusuf M. Deng JM, et al. Among authors: ahmed se. ACS Cent Sci. 2024 Jan 10;10(2):209-213. doi: 10.1021/acscentsci.3c00500. eCollection 2024 Feb 28. ACS Cent Sci. 2024. PMID: 38435513 Free PMC article. No abstract available.
Self-healing polymers for surface scratch regeneration.
Ahmed S, Jeong JE, Kim JC, Lone S, Cheong IW. Ahmed S, et al. RSC Adv. 2023 Dec 1;13(50):35050-35064. doi: 10.1039/d3ra06676b. eCollection 2023 Nov 30. RSC Adv. 2023. PMID: 38046629 Free PMC article. Review.
Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Among authors: ahmed s. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938 Free article.
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R. Epperla N, et al. Among authors: ahmed s. J Hematol Oncol. 2023 Nov 9;16(1):111. doi: 10.1186/s13045-023-01508-3. J Hematol Oncol. 2023. PMID: 37946255 Free PMC article.
11,760 results
You have reached the last available page of results. Please see the User Guide for more information.